Moller Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-6,653
Closed -$1.53M 49
2020
Q4
$1.53M Buy
+6,653
New +$1.53M 0.63% 26
2019
Q1
Sell
-8,172
Closed -$1.61M 57
2018
Q4
$1.61M Buy
+8,172
New +$1.59M 1.05% 19
2014
Q4
Sell
-8,282
Closed -$1.16M 46
2014
Q3
$1.16M Hold
8,282
0.55% 24
2014
Q2
$980K Sell
8,282
-6,098
-42% -$706K 0.45% 29
2014
Q1
$1.77M Sell
14,380
-162
-1% -$19.6K 0.91% 16
2013
Q4
$1.66M Sell
14,542
-366
-2% -$41.6K 0.89% 19
2013
Q3
$1.67M Hold
14,908
1.05% 17
2013
Q2
$1.47M Buy
+14,908
New +$1.55M 1.07% 18

Other funds holding AMGN

Moller Wealth Partners's AMGN Position: Q1 2021 in Review

Moller Wealth Partners sold out of Amgen (AMGN) in Q1 2021, closing a stake of 6,653 shares — an estimated $1.53M sold.

Moller Wealth Partners first reported a position in AMGN in Q2 2013 and held it in 8 quarters. The position peaked at $1.77M in Q1 2014. 2,218 funds tracked by Wall St. Rank hold AMGN as of Q1 2021.

  • Moller Wealth Partners reported no remaining Amgen position as of Q1 2021 after selling out during the quarter.
  • Moller Wealth Partners sold 6,653 Amgen shares in Q1 2021, an estimated $1.53M.
  • Moller Wealth Partners first reported a position in Amgen in Q2 2013 and held it in 8 quarters.
  • Moller Wealth Partners's Amgen position peaked at $1.77M in Q1 2014.
  • 2,218 funds tracked by Wall St. Rank held Amgen as of Q1 2021.

Based on Moller Wealth Partners's 13F filing for Q1 2021, filed 19 Apr 2021.